MF
AZN icon

Magnetar Financial’s AstraZeneca AZN Stock Holding History

Magnetar Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,449
Closed -$1.86M – 1175
2026
Q1 		$1.86M Buy
+9,449
New +$1.82M 0.02% 336
2024
Q4 		– Sell
-240,000
Closed -$37.4M – 616
2024
Q3 		$37.4M Buy
+240,000
New +$38.7M 0.81% 44
2024
Q2 		– Sell
-440,417
Closed -$59.7M – 510
2024
Q1 		$59.7M Buy
440,417
+381,507
+648% +$50.5M 1.34% 21
2023
Q4 		$7.94M Buy
+58,910
New +$7.66M 0.2% 86
2023
Q3 		– Sell
-227,568
Closed -$32.6M – 453
2023
Q2 		$32.6M Buy
227,568
+123,783
+119% +$18.2M 0.71% 50
2023
Q1 		$14.4M Buy
+103,785
New +$14M 0.28% 87
2022
Q4 		– Sell
-85,629
Closed -$9.39M – 785
2022
Q3 		$9.39M Buy
+85,629
New +$10.9M 0.13% 197
2021
Q4 		– Sell
-130,898
Closed -$15.7M – 1373
2021
Q3 		$15.7M Sell
130,898
-159,062
-55% -$18.5M 0.16% 135
2021
Q2 		$34.7M Sell
289,960
-222,274
-43% -$24.4M 0.33% 52
2021
Q1 		$50.9M Buy
512,234
+246,118
+92% +$24.7M 0.49% 35
2020
Q4 		$26.6M Buy
266,116
+251,116
+1,674% +$26.6M 0.38% 53
2020
Q3 		$1.64M Sell
15,000
-75,833
-83% -$8.43M 0.03% 278
2020
Q2 		$9.61M Sell
90,833
-80,173
-47% -$8.28M 0.28% 86
2020
Q1 		$15.3M Sell
171,006
-157,042
-48% -$14.8M 0.37% 56
2019
Q4 		$32.7M Buy
328,048
+23,229
+8% +$2.19M 0.68% 30
2019
Q3 		$27.2M Buy
304,819
+47,369
+18% +$4.11M 0.69% 25
2019
Q2 		$21.3M Buy
257,450
+64,950
+34% +$5.09M 0.43% 39
2019
Q1 		$15.6M Buy
192,500
+96,500
+101% +$7.61M 0.4% 36
2018
Q4 		$7.29M Buy
96,000
+8,500
+10% +$664K 0.18% 62
2018
Q3 		$6.92M Buy
+87,500
New +$6.62M 0.13% 73

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Magnetar Financial's AZN Position: Q2 2026 in Review

Magnetar Financial sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 9,449 shares — an estimated $1.86M sold.

Magnetar Financial first reported a position in AZN in Q3 2018 and held it in 20 quarters. The position peaked at $59.7M in Q1 2024. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Magnetar Financial reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 9,449 AstraZeneca shares in Q2 2026, an estimated $1.86M.
  • Magnetar Financial first reported a position in AstraZeneca in Q3 2018 and held it in 20 quarters.
  • Magnetar Financial's AstraZeneca position peaked at $59.7M in Q1 2024.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.